DIAGENS

China
Hengyang, Hunan, China

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$44.4M
Last funding
Series C / $14.1M / 2023-12-29
Last equity funding
Series C / $14.1M
Investors
9
Lead investors
2
Articles
2

Founders and investors

Lead investors

Grand Flight InvestmentMeihong Investment

Investors

China Venture Capital HRVCGrand Flight InvestmentHaiyuan CapitalShenzhen Guozhong Venture Capital ManagementWinning Ventures